Patents Assigned to Benuvia Therapeutics LLC
  • Oral Cannabinoid Formulations
    Publication number: 20220160626
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Application
    Filed: February 14, 2022
    Publication date: May 26, 2022
    Applicant: Benuvia Therapeutics, LLC
    Inventors: VENKAT R GOSKONDA, Ashok Chavan, Amit Kokate, Howard Gil
  • Oral cannabinoid formulations
    Patent number: 11253472
    Abstract: Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: February 22, 2022
    Assignee: Benuvia Therapeutics LLC
    Inventors: Venkat R. Goskonda, Ashok Chavan, Amit Kokate, Howard Gill